D-0486-2026 Class II Ongoing
FDA drug recall D-0486-2026 was initiated by Leading Pharma, LLC on Mar 20, 2026 and is designated Class II. Reason for recall: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit. The recall status is ongoing. Affected quantity: 9384 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 29, 2026
- Initiation Date
- Mar 20, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9384 bottles
Product description
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
Reason for recall
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Distribution pattern
US Nationwide.
Code information
Lots# H03125, H03225, H03325, Exp Date: 2027/08
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0486-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026